RCS - Access Accelerated - Access Accelerated Releases Six-Year Report

Bayer AGAnnouncement

24/05/2023 09:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230524:nRSX4803Aa&default-theme=true

RNS Number : 4803A  Access Accelerated  24 May 2023

New Access Accelerated Global Collective Report Charts Path Forward in Fight
Against Noncommunicable Diseases

Access Accelerated and Partners Unveil Findings From Six-Year Report

GENEVA, SWITZERLAND / ACCESSWIRE / May 24, 2023 / Access Accelerated
(https://pr.report/S6iMj5Ka) , a pioneering collective of leading
biopharmaceutical and life science companies dedicated to confronting the
growing global noncommunicable disease (NCD) crisis, announced the release of
a six-year report: Key Lessons in Advancing Access to NCD Care: Collaboration,
Connectivity, Community. (https://pr.report/9co7txJb)

Access Accelerated

Access Accelerated logo

This milestone report highlights the initiative's outcomes, impact, and
collective learnings between 2017 and 2022 and serves as a retrospective, a
showcase for the initiative's success stories and challenges, and a
much-needed vision for the future.

Michael Fredrich, Lead Access to Medicine Non-Communicable Diseases at Bayer
Pharmaceuticals and Chair of the Access Accelerated Board, commented, "With
the 2030 deadline for the UN Sustainable Development Goals approaching fast,
which include Universal Health Coverage, it's more important than ever that we
make the most out of our resources and approach this fight strategically. This
report gives us the opportunity to critically evaluate our past and use key
learnings for the future. It is essential that we share insights and learn
from our collective efforts. Much work lies ahead, but this report serves as a
valuable foundation for effectively addressing NCDs."

This initiative's impact has already been felt widely. Access Accelerated and
its strategic partners - the City Cancer Challenge Foundation, NCD Alliance,
PATH, the World Bank and the World Heart Federation - have helped improve
access to NCD screening, diagnosis, and treatment around the world, reaching
over 700 million people through 54 partner projects in 37 countries and
catalyzing $US1.6 billion in investment in 2022 alone. By the end of phase 2
(2020-2022), this number totalled $US3.7 billion. In the same period, Access
Accelerated partner projects contributed to policy change in 35 countries and
13 projects were scaled to national level, moving away from pilot phase to
locally embedded projects.

Six years since its founding, the initiative has accumulated a wealth of
hard-won knowledge and experience. The report highlights those learnings,
including the crucial role of open, transparent communication in measuring
intangible impact of partnerships, the ways flexible long-term funding can
open the way for locally embedded solutions, and why community- and
patient-centric approaches are essential to sustainability. By capturing
impacts beyond hard numbers, the report demonstrates the importance of local
engagement, trust, and social capital in improving NCD outcomes over time.

According to Dr. Juan Pablo Uribe, World Bank's Global Director for Health,
Nutrition & Population and Director of the Global Financing Facility, the
report demonstrates the importance of rigorous monitoring and reporting.
"Learning from our successes and challenges is absolutely necessary if we are
going to shape more efficient and effective initiatives that can respond to
the growing NCD burden on countries around the world. That's why we're excited
to have the insights offered by this report to inform future initiatives and
are grateful to the partnership with Access Accelerated which has led to
meaningful action in creating sustainable change."

Visit www.accessaccelerated.org (https://pr.report/C3D6OuEK) to download the
report.

About Access Accelerated

Founded in 2017, Access Accelerated is an unprecedented industry-led
collective of life science companies united by the belief that no person
should die from a preventable and treatable disease. Through the power of
collaboration and a proven framework for cooperation, Access Accelerated
brings together stakeholders across the private, public and social sectors,
including implementers, decision-makers and financiers, in a shared mission of
advancing action against the escalating challenge of NCDs in low- and
middle-income countries and underserved communities.

Contact Information

Thuy Khuc-Bilon

Communications Manager
info@accessaccelerated.org (mailto:info@accessaccelerated.org)

+41 79 473 0341

SOURCE: Access Accelerated

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRAUSUVRORUVURR